Fusion Pharmaceuticals Inc. (FUSN)

Fusion Pharmaceuticals Revenue

Fusion Pharmaceuticals had revenue of $2.04M in the twelve months ending March 31, 2024, with 125.66% growth year-over-year. In the year 2023, Fusion Pharmaceuticals had annual revenue of $2.07M with 41.55% growth.

• Revenue (ttm): $2.04M
• Revenue Growth: +125.66%
• P/S Ratio: 896.26
• Revenue / Employee: $20,198
• Employees: 101
• Market Cap: 1.83B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.07M	607.00K	41.55%
Dec 31, 2022	1.46M	21.00K	1.46%
Dec 31, 2021	1.44M	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.